Financing type:  underwritten prospectus offering

Gross proceeds:  $40,004,000

Offering:  54.8 million listed shares

Offering price:  73 cents per listed share

Overallotment option:  The underwriters may purchase a maximum of 8.22 million listed shares for overallotment purposes. As of Nov. 28, 2025, such option remains outstanding and no listed shares have been issued thereunder.

Commissions in securities:  not applicable(commission in cash only)

Disclosure:  Refer to the prospectus dated Nov. 21, 2025, and the company's news releases dated Nov. 12, 2025, Nov. 21, 2025, and Nov. 26, 2025.